DOCSLIB.ORG

New Tools for Studying Microglia in the Mouse and Human CNS

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
New Tools for Studying Microglia in the Mouse and Human CNS New tools for studying microglia in the mouse and human CNS Mariko L. Bennetta,1,F.ChrisBennetta,b, Shane A. Liddelowa,c, Bahareh Ajamid, Jennifer L. Zamaniana, Nathaniel B. Fernhoffe,f,g,h, Sara B. Mulinyawea, Christopher J. Bohlena, Aykezar Adila, Andrew Tuckera, Irving L. Weissmane,f,g,h, Edward F. Changi, Gordon Lij, Gerald A. Grantj, Melanie G. Hayden Gephartj, and Ben A. Barresa,1 aDepartment of Neurobiology, Stanford University School of Medicine, Stanford, CA 94305; bDepartment of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA 94305; cDepartment of Pharmacology and Therapeutics, University of Melbourne, Melbourne, VIC, Australia, 3010; dDepartment of Neurology, Stanford University School of Medicine, Stanford, CA 94305; eInstitute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA 94305; fLudwig Center for Cancer Stem Cell Research and Medicine, Stanford University School of Medicine, Stanford, CA 94305; gStanford Cancer Institute, Stanford University School of Medicine, Stanford, CA 94305; hDepartment of Pathology, Stanford University School of Medicine, Stanford, CA 94305; iUniversity of California, San Francisco Epilepsy Center, University of California, San Francisco, CA 94143; and jDepartment of Neurosurgery, Stanford University School of Medicine, Stanford, CA 94305 Contributed by Ben A. Barres, January 12, 2016 (sent for review November 8, 2015; reviewed by Roman J. Giger and Beth Stevens) The specific function of microglia, the tissue resident macrophages and well-validated antibodies to known antigens yet exist to of the brain and spinal cord, has been difficult to ascertain because specifically and stably identify microglia. of a lack of tools to distinguish microglia from other immune cells, Therefore, we sought a molecular marker that would allow for thereby limiting specific immunostaining, purification, and manipu- the identification, isolation, and study of microglia across many lation. Because of their unique developmental origins and predicted applications. Whereas several studies have proposed potential functions, the distinction of microglia from other myeloid cells is microglia-specific markers (15–17), none have systematically critically important for understanding brain development and dis- validated these candidates, elucidated whether the markers ease; better tools would greatly facilitate studies of microglia function identified all microglia, or developed microglia-specific anti- in the developing, adult, and injured CNS. Here, we identify trans- bodies for use by the larger neuroscience community. Here we membrane protein 119 (Tmem119), a cell-surface protein of unknown identify and describe transmembrane protein 119 (Tmem119) as function, as a highly expressed microglia-specific marker in both a microglia-specific marker in both mouse and human CNS. We mouse and human. We developed monoclonal antibodies to its developed rabbit monoclonal antibodies against the intracellular intracellular and extracellular domains that enable the immuno- and extracellular domains of mouse Tmem119 for use in im- staining of microglia in histological sections in healthy and diseased munohistochemical identification and FACS isolation of brains, as well as isolation of pure nonactivated microglia by FACS. microglia, respectively. We adapted existing isolation methods to Using our antibodies, we provide, to our knowledge, the first generate what are, to our knowledge, the first ever RNA sequencing RNAseq profiles of highly pure mouse microglia during develop- profiles of pure, nonactivated microglia during development ment and after an immune challenge. We used these to demon- strate that mouse microglia mature by the second postnatal week Significance and to predict novel microglial functions. Together, we antici- pate these resources will be valuable for the future study and understanding of microglia in health and disease. Microglia are the tissue resident macrophages of the brain and spinal cord, implicated in important developmental, homeo- microglia | glia | developmental neuroscience | RNAseq | macrophage static, and disease processes, although our understanding of their roles is complicated by an inability to distinguish micro- glia from related cell types. Although they share many features icroglia are the resident parenchymal myeloid cells of the with other macrophages, microglia have distinct developmental MCNS, with important roles in development, homeostasis, origins and functions. Here we validate a stable and robustly disease, and injury (1). A major limitation to dissecting microglia- expressed microglial marker for both mouse and human, trans- specific contributions to these processes is an inability to distin- membrane protein 119 (Tmem119). We use custom-made anti- guish microglia from related cells, such as macrophages. The bodies against Tmem119 to perform deep RNA sequencing of importance of this distinction is increasingly clear, because micro- developing microglia, and demonstrate that microglia mature by glia not only have unique origins and developmental transcriptional the second postnatal week in mice. The antibodies, cell isolation programs, but are self-renewing and function differently than in- – methods, and RNAseq profiles presented here will greatly facilitate filtrating macrophages in CNS disease and injury (2 4). our understanding of microglial function in health and disease. Until recently, methods to distinguish microglia from other CNS cells relied on morphological distinctions (ramified vs. amoeboid), Author contributions: M.L.B., F.C.B., and B.A.B. designed research; M.L.B., F.C.B., S.A.L., relative marker expression by flow cytometry (the common B.A., N.B.F., S.B.M., C.J.B., A.A., and A.T. performed research; M.L.B., J.L.Z., I.L.W., E.F.C., G.L., leukocyte antigen CD45hi/lo) (5), or generating bone marrow G.A.G., and M.G.H.G. contributed new reagents/analytic tools; M.L.B., F.C.B., B.A., and (BM) chimeras (6, 7). Unfortunately, these approaches have B.A.B. analyzed data; M.L.B. and B.A.B. wrote the paper; and I.L.W. performed BMT exper- iments in his laboratory. inherent limitations. First, parameters such as morphology or Reviewers: R.J.G., University of Michigan; and B.S., Harvard Medical School Children’s CD45 expression may change with disease or injury. Second, Hospital. chimeric mouse generation leads to partial chimerism, causes The authors declare no conflict of interest. inflammatory damage, and can take many months (8, 9). More Freely available online through the PNAS open access option. recently, tools based on microglial expression of the fractalkine Data deposition: The sequence reported in this paper has been deposited in the NCBI receptor, Cx3cr1, overcame some of these limitations. The gen- BioProject, www.ncbi.nlm.nih.gov/bioproject (accession no. PRJNA307271). eration of knockin Cx3cr1-GFP (10) and Cx3cr1-CreERT (11, 12) See Commentary on page 3130. mice advanced the specificity and sophistication with which to 1 To whom correspondence may be addressed. Email: [email protected] or study microglial function. Cx3cr1, however, is also highly [email protected]. lo expressed by circulating monocytes (Ly6C ) and other tissue This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10. resident macrophages (10, 13, 14). In addition, no widely available 1073/pnas.1525528113/-/DCSupplemental. E1738–E1746 | PNAS | Published online February 16, 2016 www.pnas.org/cgi/doi/10.1073/pnas.1525528113 Downloaded by guest on September 23, 2021 and activated microglia following systemic inflammation. We Custom Anti-Tmem119 Monoclonal Antibodies Specifically Identify PNAS PLUS added these data to a user-friendly website (www.BrainRNAseq. Microglia. Tmem119 is a type IA single-pass transmembrane org). For human study, we identified and validated an anti-human protein with a reported role in osteoblast differentiation (23, 24). TMEM119 rabbit polyclonal antiserum that specifically stains Because no specific anti-mouse Tmem119 antibodies existed, we microglia in postmortem and surgical human brain sections. To- made two different monoclonal antibodies (mAbs) against the gether, the new microglial tools we developed have the potential to predicted extracellular (ECD) and intracellular (ICD) domains of mouse Tmem119 (SI Appendix, Fig. S2A). We stained cryo- broadly enable studies of microglia function in health and disease. + sections from Cx3cr1GFP/ × Tmem119 WT and knockout (KO) Results mice, as well as WT and KO lacking Cx3cr1-GFP. Both mAbs Tmem119 mRNA Expression Is Highly Enriched in the CNS and Specific demonstrated robust microglial staining in WT but not KO tis- SEE COMMENTARY to Most or all Microglia. To identify a microglia-specific marker, sues (Fig. 2 A and G and SI Appendix, Fig. S2B). The ICD mAb we generated a microglia-enriched gene expression profile of immunostained the microglial cell surface, revealing many fine + processes not apparent by classic markers (Fig. 2 B and C). CD45 immunopanned brain leukocytes from adult mice (18). + + Comparing these data with our datasets of highly pure CNS cells Staining was limited to parenchymal Cx3cr1-GFP and Iba1 and profiles of acutely purified immune cells (18–22), we iden- cells, and absent from meninges or choroid plexus, consistent with Tmem119 mRNA (Fig. 2 A–D and SI Appendix,Fig.S2C–G). tified seven highly expressed and enriched candidates: Tmem119, + By flow cytometry, ECD mAbs
Load more

Recommended publications
  • Lysophosphatidic Acid and Its Receptors: Pharmacology and Therapeutic Potential in Atherosclerosis and Vascular Disease
    JPT-107404; No of Pages 13 Pharmacology & Therapeutics xxx (2019) xxx Contents lists available at ScienceDirect Pharmacology & Therapeutics journal homepage: www.elsevier.com/locate/pharmthera Lysophosphatidic acid and its receptors: pharmacology and therapeutic potential in atherosclerosis and vascular disease Ying Zhou a, Peter J. Little a,b, Hang T. Ta a,c, Suowen Xu d, Danielle Kamato a,b,⁎ a School of Pharmacy, University of Queensland, Pharmacy Australia Centre of Excellence, Woolloongabba, QLD 4102, Australia b Department of Pharmacy, Xinhua College of Sun Yat-sen University, Tianhe District, Guangzhou 510520, China c Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, St Lucia, QLD 4072, Australia d Aab Cardiovascular Research Institute, Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA article info abstract Available online xxxx Lysophosphatidic acid (LPA) is a collective name for a set of bioactive lipid species. Via six widely distributed G protein-coupled receptors (GPCRs), LPA elicits a plethora of biological responses, contributing to inflammation, Keywords: thrombosis and atherosclerosis. There have recently been considerable advances in GPCR signaling especially Lysophosphatidic acid recognition of the extended role for GPCR transactivation of tyrosine and serine/threonine kinase growth factor G-protein coupled receptors receptors. This review covers LPA signaling pathways in the light of new information. The use of transgenic and Atherosclerosis gene knockout animals, gene manipulated cells, pharmacological LPA receptor agonists and antagonists have Gproteins fi β-arrestins provided many insights into the biological signi cance of LPA and individual LPA receptors in the progression Transactivation of atherosclerosis and vascular diseases.
    [Show full text]
  • NIH Public Access Author Manuscript Neuron Glia Biol
    NIH Public Access Author Manuscript Neuron Glia Biol. Author manuscript; available in PMC 2006 May 1. NIH-PA Author ManuscriptPublished NIH-PA Author Manuscript in final edited NIH-PA Author Manuscript form as: Neuron Glia Biol. 2006 May ; 2(2): 125±138. Purinergic receptors activating rapid intracellular Ca2+ increases in microglia Alan R. Light1, Ying Wu2, Ronald W. Hughen1, and Peter B. Guthrie3 1 Department of Anesthesiology, University of Utah, Salt Lake City, UT, USA 2 Oral Biology Program, School of Dentistry, University of North Carolina at Chapel Hill, Chapel Hill, NC 27510, USA 3 Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4142 Msc 7850, Bethesda, MD 20892-7850, USA Abstract We provide both molecular and pharmacological evidence that the metabotropic, purinergic, P2Y6, P2Y12 and P2Y13 receptors and the ionotropic P2X4 receptor contribute strongly to the rapid calcium response caused by ATP and its analogues in mouse microglia. Real-time PCR demonstrates that the most prevalent P2 receptor in microglia is P2Y6 followed, in order, by P2X4, P2Y12, and P2X7 = P2Y13. Only very small quantities of mRNA for P2Y1, P2Y2, P2Y4, P2Y14, P2X3 and P2X5 were found. Dose-response curves of the rapid calcium response gave a potency order of: 2MeSADP>ADP=UDP=IDP=UTP>ATP>BzATP, whereas A2P4 had little effect. Pertussis toxin partially blocked responses to 2MeSADP, ADP and UDP. The P2X4 antagonist suramin, but not PPADS, significantly blocked responses to ATP. These data indicate that P2Y6, P2Y12, P2Y13 and P2X receptors mediate much of the rapid calcium responses and shape changes in microglia to low concentrations of ATP, presumably at least partly because ATP is rapidly hydrolyzed to ADP.
    [Show full text]
  • Myelin Biogenesis Is Associated with Pathological Ultrastructure That Is
    bioRxiv preprint doi: https://doi.org/10.1101/2021.02.02.429485; this version posted February 4, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 1 Myelin biogenesis is associated with pathological ultrastructure that 2 is resolved by microglia during development 3 4 5 Minou Djannatian1,2*, Ulrich Weikert3, Shima Safaiyan1,2, Christoph Wrede4, Cassandra 6 Deichsel1,2, Georg Kislinger1,2, Torben Ruhwedel3, Douglas S. Campbell5, Tjakko van Ham6, 7 Bettina Schmid2, Jan Hegermann4, Wiebke Möbius3, Martina Schifferer2,7, Mikael Simons1,2,7* 8 9 1Institute of Neuronal Cell Biology, Technical University Munich, 80802 Munich, Germany 10 2German Center for Neurodegenerative Diseases (DZNE), 81377 Munich, Germany 11 3Max-Planck Institute of Experimental Medicine, 37075 Göttingen, Germany 12 4Institute of Functional and Applied Anatomy, Research Core Unit Electron Microscopy, 13 Hannover Medical School, 30625, Hannover, Germany 14 5Department of Neuronal Remodeling, Graduate School of Pharmaceutical Sciences, Kyoto 15 University, Sakyo-ku, Kyoto 606-8501, Japan. 16 6Department of Clinical Genetics, Erasmus MC, University Medical Center Rotterdam, 3015 CN, 17 the Netherlands 18 7Munich Cluster of Systems Neurology (SyNergy), 81377 Munich, Germany 19 20 *Correspondence: [email protected] or [email protected] 21 Keywords 22 Myelination, degeneration, phagocytosis, microglia, oligodendrocytes, phosphatidylserine 23 24 1 bioRxiv preprint doi: https://doi.org/10.1101/2021.02.02.429485; this version posted February 4, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
    [Show full text]
  • Blood Platelet Adenosine Receptors As Potential Targets for Anti-Platelet Therapy
    International Journal of Molecular Sciences Review Blood Platelet Adenosine Receptors as Potential Targets for Anti-Platelet Therapy Nina Wolska and Marcin Rozalski * Department of Haemostasis and Haemostatic Disorders, Chair of Biomedical Science, Medical University of Lodz, 92-215 Lodz, Poland; [email protected] * Correspondence: [email protected]; Tel.: +48-504-836-536 Received: 30 September 2019; Accepted: 1 November 2019; Published: 3 November 2019 Abstract: Adenosine receptors are a subfamily of highly-conserved G-protein coupled receptors. They are found in the membranes of various human cells and play many physiological functions. Blood platelets express two (A2A and A2B) of the four known adenosine receptor subtypes (A1,A2A, A2B, and A3). Agonization of these receptors results in an enhanced intracellular cAMP and the inhibition of platelet activation and aggregation. Therefore, adenosine receptors A2A and A2B could be targets for anti-platelet therapy, especially under circumstances when classic therapy based on antagonizing the purinergic receptor P2Y12 is insufficient or problematic. Apart from adenosine, there is a group of synthetic, selective, longer-lasting agonists of A2A and A2B receptors reported in the literature. This group includes agonists with good selectivity for A2A or A2B receptors, as well as non-selective compounds that activate more than one type of adenosine receptor. Chemically, most A2A and A2B adenosine receptor agonists are adenosine analogues, with either adenine or ribose substituted by single or multiple foreign substituents. However, a group of non-adenosine derivative agonists has also been described. This review aims to systematically describe known agonists of A2A and A2B receptors and review the available literature data on their effects on platelet function.
    [Show full text]
  • View Software
    TLR4-activated microglia have divergent effects on oligodendrocyte lineage cells DISSERTATION Presented in partial fulfillment of the requirements for the Degree Doctor of Philosophy in the Graduate School of The Ohio State University Evan Zachary Goldstein, BA Neuroscience Graduate Program The Ohio State University 2016 Dissertation Committee: Dr. Dana McTigue, Advisor Dr. Phillip Popovich Dr. Jonathan Godbout Dr. Courtney DeVries Copyright by Evan Zachary Goldstein 2016 i Abstract Myelin accelerates action potential conduction velocity and provides essential metabolic support for axons. Unfortunately, myelin and myelinating cells are often vulnerable to injury or disease, resulting in myelin damage, which in turn can lead to axon dysfunction, overt pathology and neurological impairment. Inflammation is a common component of CNS trauma and disease, and therefore an active inflammatory response is often considered deleterious to myelin health. While inflammation can certainly damage myelin, inflammatory processes also benefit oligodendrocyte (OL) lineage progression and myelin repair. Consistent with the divergent nature of inflammation, intraspinal toll-like receptor 4 (TLR4) activation, an innate immune pathway, kills OL lineage cells, but also initiates oligodendrogenesis. Soluble factors produced by TLR4-activated microglia can reproduce these effects in vitro, however the exact factors are unknown. To determine what microglial factors might contribute to TLR4-induced OL loss and oligodendrogenesis, mRNA of factors known to affect OL lineage cells was quantified in TLR4-activated microglia and spinal cords (chapter 2). Results indicate that TLR4-activated microglia transcribe numerous factors that induce OL loss, OL progenitor cell (OPC) proliferation and OPC differentiation. However, some factors upregulated after intraspinal TLR4 activation were not ii upregulated by microglia, suggesting that other cell types contribute to transcriptional changes in vivo.
    [Show full text]
  • Tecnicas Microscopicas
    CAP 1: TÉCNICAS MICROSCÓPICAS TÉCNICAS MICROSCÓPICAS 11 Lic. Carlos R. Neira Montoya Lic. Eduardo Sedano Gelvet Lic. María Elena Vilcarromero V. El estudio de los tejidos tal como los observamos hoy en día no sería posible sin la ayuda de la histotecnología; esta disciplina se encarga del estudio de los métodos técnicas y procedimientos que permiten la transformación de un órgano en una película lo suficientemente transparente y contrastada que nos permite su observación a través del microscopio (Fig. 1-1). Para que esto ocurra se tiene que seguir una serie de pasos. Cada uno de estos pasos permite la observación de las características morfológicas del tejido que nos indica la normalidad o la alteración patológica; sin embargo en estudios mucho más minuciosos, estos pasos se harán en función de las estructuras o sustancias que se deseen investigar en la muestra correspondiente. Figura 1-1. Un órgano es transformado en una película transparente. - Pág. 5 - CAP 1: TÉCNICAS MICROSCÓPICAS Los pasos de las técnicas microscópicas para obtener un preparado histológico permanente (láminas) son: 1. Toma de la muestra. 2. Fijación. 3. Inclusión. 4. Microtomía. 5. Coloración. 1. TOMA DE LA MUESTRA Es el momento que se selecciona el órgano o tejido a estudiar. De tres fuentes puede provenir el material humano: las necropsias, las biopsias y las piezas operadas. De éstas, sólo la primera puede darnos material normal; las dos últimas habitualmente proporcionarán tejidos para estudio histopatológico. - Necropsias: son las piezas que se obtienen de un cadáver. Para histología normal es necesario que se trate de un cadáver fresco y que no haya sido atacado por ninguna lesión, por lo menos el órgano que se quiere estudiar.
    [Show full text]
  • Nomina Histologica Veterinaria, First Edition
    NOMINA HISTOLOGICA VETERINARIA Submitted by the International Committee on Veterinary Histological Nomenclature (ICVHN) to the World Association of Veterinary Anatomists Published on the website of the World Association of Veterinary Anatomists www.wava-amav.org 2017 CONTENTS Introduction i Principles of term construction in N.H.V. iii Cytologia – Cytology 1 Textus epithelialis – Epithelial tissue 10 Textus connectivus – Connective tissue 13 Sanguis et Lympha – Blood and Lymph 17 Textus muscularis – Muscle tissue 19 Textus nervosus – Nerve tissue 20 Splanchnologia – Viscera 23 Systema digestorium – Digestive system 24 Systema respiratorium – Respiratory system 32 Systema urinarium – Urinary system 35 Organa genitalia masculina – Male genital system 38 Organa genitalia feminina – Female genital system 42 Systema endocrinum – Endocrine system 45 Systema cardiovasculare et lymphaticum [Angiologia] – Cardiovascular and lymphatic system 47 Systema nervosum – Nervous system 52 Receptores sensorii et Organa sensuum – Sensory receptors and Sense organs 58 Integumentum – Integument 64 INTRODUCTION The preparations leading to the publication of the present first edition of the Nomina Histologica Veterinaria has a long history spanning more than 50 years. Under the auspices of the World Association of Veterinary Anatomists (W.A.V.A.), the International Committee on Veterinary Anatomical Nomenclature (I.C.V.A.N.) appointed in Giessen, 1965, a Subcommittee on Histology and Embryology which started a working relation with the Subcommittee on Histology of the former International Anatomical Nomenclature Committee. In Mexico City, 1971, this Subcommittee presented a document entitled Nomina Histologica Veterinaria: A Working Draft as a basis for the continued work of the newly-appointed Subcommittee on Histological Nomenclature. This resulted in the editing of the Nomina Histologica Veterinaria: A Working Draft II (Toulouse, 1974), followed by preparations for publication of a Nomina Histologica Veterinaria.
    [Show full text]
  • Purinergic Receptors Brian F
    Chapter 21 Purinergic receptors Brian F. King and Geoffrey Burnstock 21.1 Introduction The term purinergic receptor (or purinoceptor) was first introduced to describe classes of membrane receptors that, when activated by either neurally released ATP (P2 purinoceptor) or its breakdown product adenosine (P1 purinoceptor), mediated relaxation of gut smooth muscle (Burnstock 1972, 1978). P2 purinoceptors were further divided into five broad phenotypes (P2X, P2Y, P2Z, P2U, and P2T) according to pharmacological profile and tissue distribution (Burnstock and Kennedy 1985; Gordon 1986; O’Connor et al. 1991; Dubyak 1991). Thereafter, they were reorganized into families of metabotropic ATP receptors (P2Y, P2U, and P2T) and ionotropic ATP receptors (P2X and P2Z) (Dubyak and El-Moatassim 1993), later redefined as extended P2Y and P2X families (Abbracchio and Burnstock 1994). In the early 1990s, cDNAs were isolated for three heptahelical proteins—called P2Y1, P2Y2, and P2Y3—with structural similarities to the rhodopsin GPCR template. At first, these three GPCRs were believed to correspond to the P2Y, P2U, and P2T receptors. However, the com- plexity of the P2Y receptor family was underestimated. At least 15, possibly 16, heptahelical proteins have been associated with the P2Y receptor family (King et al. 2001, see Table 21.1). Multiple expression of P2Y receptors is considered the norm in all tissues (Ralevic and Burnstock 1998) and mixtures of P2 purinoceptors have been reported in central neurones (Chessell et al. 1997) and glia (King et al. 1996). The situation is compounded by P2Y protein dimerization to generate receptor assemblies with subtly distinct pharmacological proper- ties from their constituent components (Filippov et al.
    [Show full text]
  • P2Y12-Dependent Modulation of ADP-Evoked Calcium Responses in Human Monocytes
    P2Y12-dependent modulation of ADP-evoked calcium responses in human monocytes Jonathon J. Micklewright A thesis submitted for the degree of Master of Science by Research University of East Anglia School of Biological Sciences February 2018 © This copy of the thesis has been supplied on condition that anyone who consults it is understood to recognise that its copyright rests with the author and that use of any information derived there from must be in accordance with current UK Copyright Law. In addition, any quotation or extract must include full attribution. Abstract The Gi-coupled, ADP-activated P2Y12 receptor is well-characterised as playing a key role in platelet activation via crosstalk with P2Y1. A crucial aspect of P2Y12-P2Y1 crosstalk in platelets involves ADP-induced intracellular calcium (Ca2+) mobilisation, however there is limited knowledge on the role of P2Y12 in ADP-evoked Ca2+ responses in other blood cells. Here, we investigate the expression of P2Y12 in human monocytes and the contribution of P2Y12 in THP-1 ADP-evoked Ca2+ responses. RT-PCR analysis showed that all ADP-binding P2Y receptors were expressed in THP-1 monocytes at the mRNA level, with P2Y12 expressed in CD14+ primary monocytes. P2Y12 protein was found to be expressed in THP-1 cells, using immunocytochemistry. ADP- evoked Ca2+ responses in fura-2-loaded THP-1 cells were completely abolished by a sarco/endoplasmic reticulum Ca2+-ATPase inhibitor, and by a phospholipase C inhibitor, indicating that these Ca2+ responses are mediated through GPCRs. Ca2+ responses induced by ADP were significantly reduced by the P2Y12 inhibitors ticagrelor and PSB- 0739 and by the P2Y6 antagonist MRS2578, but not by P2Y1 or P2Y13 inhibitors.
    [Show full text]
  • P2X and P2Y Receptors
    Tocris Scientific Review Series Tocri-lu-2945 P2X and P2Y Receptors Kenneth A. Jacobson Subtypes and Structures of P2 Receptor Molecular Recognition Section, Laboratory of Bioorganic Families Chemistry, National Institute of Diabetes and Digestive and The P2 receptors for extracellular nucleotides are widely Kidney Diseases, National Institutes of Health, Bethesda, distributed in the body and participate in regulation of nearly Maryland 20892, USA. E-mail: [email protected] every physiological process.1,2 Of particular interest are nucleotide Kenneth Jacobson serves as Chief of the Laboratory of Bioorganic receptors in the immune, inflammatory, cardiovascular, muscular, Chemistry and the Molecular Recognition Section at the National and central and peripheral nervous systems. The ubiquitous Institute of Diabetes and Digestive and Kidney Diseases, National signaling properties of extracellular nucleotides acting at two Institutes of Health in Bethesda, Maryland, USA. Dr. Jacobson is distinct families of P2 receptors – fast P2X ion channels and P2Y a medicinal chemist with interests in the structure and receptors (G-protein-coupled receptors) – are now well pharmacology of G-protein-coupled receptors, in particular recognized. These extracellular nucleotides are produced in receptors for adenosine and for purine and pyrimidine response to tissue stress and cell damage and in the processes nucleotides. of neurotransmitter release and channel formation. Their concentrations can vary dramatically depending on circumstances. Thus, the state of activation of these receptors can be highly dependent on the stress conditions or disease states affecting a given organ. The P2 receptors respond to various extracellular mono- and dinucleotides (Table 1). The P2X receptors are more structurally restrictive than P2Y receptors in agonist selectivity.
    [Show full text]
  • Microglia Activation Triggers Astrocyte-Mediated Modulation of Excitatory Neurotransmission
    Microglia activation triggers astrocyte-mediated PNAS PLUS modulation of excitatory neurotransmission Olivier Pascuala,b,c,1,2, Sarrah Ben Achoura,b,c,2, Philippe Rostainga,b,c, Antoine Trillera,b,c, and Alain Bessisa,b,c aInstitut de Biologie de l’Ecole Normale Supérieure, F-75005 Paris, France; bInstitut National de la Santé et de la Recherche Médicale U1024, F-75005 Paris, France; and cCentre National de la Recherche Scientifique, Unité Mixte de Recherche 8197, F-75005 Paris, France Edited* by Tullio Pozzan, University of Padova, Padua, Italy, and approved November 21, 2011 (received for review July 18, 2011) Fine control of neuronal activity is crucial to rapidly adjust to subtle tatively able to sense neuronal activity and/or communicate with changes of the environment. This fine tuning was thought to be astrocytes. In response to stimuli, microglia are activated, and they purely neuronal until the discovery that astrocytes are active players release neurotransmitters (19), which are small molecules such as of synaptic transmission. In the adult hippocampus, microglia are nitric oxide, trophic factors, or cytokines, all known to control the other major glial cell type. Microglia are highly dynamic and neuronal function and synaptic transmission (20, 21). In addition, closely associated with neurons and astrocytes. They react rapidly to changes in plasticity and neuronal activity have been shown to modifications of their environment and are able to release mole- modify the resident time of microglia processes at synapses (22). cules known to control neuronal function and synaptic transmission. Although long-term effects of microglial activation and in- Therefore, microglia display functional features of synaptic part- flammation have been studied (14, 23, 24), early consequences of ners, but their involvement in the regulation of synaptic trans- such activation are still unknown, especially the cell type involved mission has not yet been addressed.
    [Show full text]
  • Role of the Serotonin Transporter and the 5-HT2A and 5-HT4 Receptors for Platelet Function in Blood
    Aus dem Institut für Prophylaxe und Epidemiologie der Kreislaufkrankheiten der Ludwig-Maximilians-Universität München Direktor: Prof. Dr. med. C. Weber Role of the serotonin transporter and the 5-HT2A and 5-HT4 receptors for platelet function in blood Dissertation zum Erwerb des Doktorgrades der Medizin an der Medizinischen Fakultät der Ludwig-Maximilians-Universität zu München Vorgelegt von Vasileios Bampalis aus Athen, Griechenland 2016 Mit Genehmigung der Medizinischen Fakultät der Universität München Berichterstatter: Prof. Dr. Med. Wolfgang Siess Mitberichterstatter: Priv. Doz. Dr. Dirk Sibbing Prof. Dr. Dr. Christian Sommerhof Dekan: Prof. Dr. med. dent. Reinhard Hickel Tag der mündlichen Prüfung: 28.01.2016 [i] Dedicated to my parents [ii] Contents Contents ........................................................................................................................ iii 1. State of the art ............................................................................................................ 1 1.1 Introduction: Serotonin, the happiness hormone .................................................. 1 1.2 Biosynthesis and degradation of 5-HT .................................................................... 2 1.3 5-HT transporter (SERT) and 5-HT receptors .......................................................... 4 1.4 Platelets and platelet function ............................................................................... 5 1.4.1 Platelet origin and morphology ......................................................................
    [Show full text]